Research programme: methyl-beta-cyclodextrin - SolAeroMedAlternative Names: Methyl-β-cyclodextrin - SolAeroMed; MβCD - SolAeroMed; S-1229
Latest Information Update: 16 Jan 2015
At a glance
- Originator SolAeroMed
- Class Cyclodextrins
- Mechanism of Action Surface active agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Acute lung injury; Adult respiratory distress syndrome
Most Recent Events
- 25 Sep 2013 Preclinical trials in Adult respiratory distress syndrome in Canada (Inhalation)
- 25 Sep 2013 Preclinical trials in Acute lung injury in Canada (Inhalation)